Filing Details

Accession Number:
0001171843-12-003463
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-09-25 06:01:25
Reporting Period:
2012-09-21
Filing Date:
2012-09-25
Accepted Time:
2012-09-25 06:01:25
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1318641 Cleveland Biolabs Inc CBLI Services-Commercial Physical & Biological Research (8731) 200077155
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1315696 James Antal C/O Cleveland Biolabs, Inc.
73 High Street
Buffalo NY 14203
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.005 Per Share Acquisiton 2012-09-21 2,316 $2.60 27,258 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 15, 2011.